Toxicities Associated with CAR T-Cell Therapy — An Interview with Dr Matthew Lunning
Hematologic Oncology Update
00:00
Infusion timing and circadian observations
Dr Lunning mentions preliminary data suggesting morning infusions might reduce CRS/ICANS and institutional review plans.
Play episode from 32:29
Transcript
